I’m not defending what Novartis did or trying to find an excuse for the company. It violated the FCPA, and (along with a former subsidiary) paid nearly $347 million in penalties and disgorgement to resolve the offenses.… Continue Reading
The World Bank debarred a business unit of a Merck subsidiary Wednesday for 12 months for a “fraudulent practice” involving a health project in Bangladesh.
Institutional Family Planning Services Department (IFPSD), a business unit of Merck Sharp & Dohme B.V.… Continue Reading
Employer: MERCK & Co., Inc.
Location: Kenilworth, New Jersey USA
Description: The position of Director, International Legal and Compliance is responsible for providing a broad range of support for marketing operations outside the United States, involving innovative pharmaceutical and vaccine products, as well as established brands. … Continue Reading
A former Merck & Co. executive bought shares in a company Merck was acquiring 14 minutes after a Merck lawyer warned him not to trade in the stock.
Yang Xie was the director of a research unit at Merck.… Continue Reading
Employer: Merck & Co., Inc
Location: Gwynedd, Pennsylvania USA
Description: The Director, ABC Compliance Officer, will be responsible for supporting high priority activities of the Company’s compliance program as they relate to the Prevention of Bribery and Corruption outside of the United States (“ABC Program”).… Continue Reading
Employer: Merck & Co., Inc.
Location: Gwynedd, PA, United States
Description: The Senior Specialist, will support the strategic execution of compliance systems and processes designed to facilitate adherence to international and national laws relating to anti-bribery and anti-corruption, monitoring and reporting and third party compliance and ethics investigations tracking.… Continue Reading
Big-pharma Merck said an SEC filing Thursday that the DOJ has closed its FCPA investigation of the company.
Merck first disclosed in 2010 that it received letters from the DOJ and SEC asking for FCPA-related information about its activities in a number of countries.… Continue Reading
Here are the first four items:
… Continue Reading
China: Glaxo Executive Says Changes in China to Cut Drug Prices
Published on Jul 24, 2013 03:00 am
GlaxoSmithKline Plc (GSK)’s head of emerging markets said after meeting with government officials in Beijing some employees may have broken China’s laws and pledged corporate changes that will deliver cheaper medicines.
A Nashville psychiatrist led the pack, earning more than $1 million during the past four years for promotional talks and consulting for seven drug companies.… Continue Reading
Authorities in Guangdong Province are responding with special seriousness to industry-wide anti-corruption regulations issued by the Ministry of Health (MOH) in July 2012.